View Single Post
Old 03-25-2021, 06:34 PM   #1
News
Senior Member
 
News's Avatar
 
Join Date: Oct 2007
Posts: 20,135
Study identifies NCOA3 as a novel therapeutic target for melanoma

For the first time, activation of nuclear receptor coactivator 3 (NCOA3) has been shown to promote the development of melanoma through regulation of ultraviolet radiation (UVR) sensitivity, cell cycle progression and circumvention of the DNA damage response.

More...
News is offline   Reply With Quote